{"id":"https://openalex.org/W2408975682","doi":null,"title":"1992 Stohlman Memorial Lecture: targeting the IL-2 receptor.","display_name":"1992 Stohlman Memorial Lecture: targeting the IL-2 receptor.","publication_year":1993,"publication_date":"1993-08-01","ids":{"openalex":"https://openalex.org/W2408975682","mag":"2408975682","pmid":"https://pubmed.ncbi.nlm.nih.gov/8361223"},"language":"en","primary_location":{"id":"pmid:8361223","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8361223","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035996420","display_name":"Thomas A. Waldmann","orcid":"https://orcid.org/0000-0003-4500-6660","observed_orcids":["https://orcid.org/0000-0003-4500-6660"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"T A Waldmann","raw_affiliation_strings":["Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5035996420"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"],"apc_list":null,"apc_paid":null,"fwci":0.3072,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.57866585,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"7 Suppl 2","issue":null,"first_page":"S151","last_page":"6"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12159","display_name":"T-cell and Retrovirus Studies","score":0.5234000086784363,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12159","display_name":"T-cell and Retrovirus Studies","score":0.5234000086784363,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.3246999979019165,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.06650000065565109,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/il-2-receptor","display_name":"interleukin-2 receptor","score":0.9129999876022339},{"id":"https://openalex.org/keywords/adult-t-cell-leukemia-lymphoma","display_name":"adult T-cell leukemia/lymphoma","score":0.781000018119812},{"id":"https://openalex.org/keywords/anti-tac-monoclonal-antibody","display_name":"anti-Tac monoclonal antibody","score":0.9729999899864197},{"id":"https://openalex.org/keywords/humanized-antibody","display_name":"humanized monoclonal antibody","score":0.8330000042915344},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.8709999918937683},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.6830000281333923},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.46399998664855957},{"id":"https://openalex.org/keywords/allograft-rejection","display_name":"allograft rejection","score":0.8029999732971191},{"id":"https://openalex.org/keywords/graft-versus-host-disease","display_name":"graft-versus-host disease","score":0.9430000185966492},{"id":"https://openalex.org/keywords/autoimmune-disease","display_name":"autoimmune disease","score":0.8259999752044678}],"concepts":[{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.7886823415756226},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6171045899391174},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.6005336046218872},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5979839563369751},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5733574032783508},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.5542162656784058},{"id":"https://openalex.org/C2779823535","wikidata":"https://www.wikidata.org/wiki/Q6865356","display_name":"Minimal residual disease","level":3,"score":0.5354092121124268},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5276930332183838},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.48654070496559143},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.38696298003196716}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000922","descriptor_name":"Immunotoxins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D008213","descriptor_name":"Lymphocyte Activation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015375","descriptor_name":"Receptors, Interleukin-2","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015375","descriptor_name":"Receptors, Interleukin-2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015459","descriptor_name":"Leukemia-Lymphoma, Adult T-Cell","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":false},{"descriptor_ui":"D015459","descriptor_name":"Leukemia-Lymphoma, Adult T-Cell","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:8361223","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8361223","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia","raw_type":"Journal Article"},{"id":"mag:2408975682","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8361223","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W52583696","https://openalex.org/W7100307617","https://openalex.org/W1970119799","https://openalex.org/W2413679075","https://openalex.org/W35887377","https://openalex.org/W2110812104","https://openalex.org/W2215316452","https://openalex.org/W2089732337","https://openalex.org/W2027320736","https://openalex.org/W1499156289"],"abstract_inverted_index":{"Patients":[0],"with":[1,11,40,89,133,166],"human":[2,97],"T-cell":[3,42],"lymphotropic":[4],"virus":[5],"I":[6],"(HTLV-I)-associated":[7],"leukemia/lymphoma":[8],"were":[9],"treated":[10,45,168],"different":[12],"forms":[13],"of":[14,37,92,144,162,181,191,198],"IL-2":[15],"receptor":[16],"(IL-2R)-directed":[17],"therapy":[18,183],"that":[19,81],"exploit":[20],"the":[21,38,83,87,90,93,107,117,150,163,178,189,196],"difference":[22],"in":[23,50,114,146],"IL-2R":[24],"expression":[25],"between":[26],"normal":[27],"and":[28,68,135,137,155,194,204],"malignant":[29],"cells.":[30],"Using":[31],"unmodified":[32,60],"anti-Tac":[33,78,130],"monoclonal":[34,61],"antibody,":[35,119],"one-third":[36],"patients":[39,165],"adult":[41],"leukemia":[43],"(ATL)":[44],"have":[46],"undergone":[47],"a":[48,141,185],"remission,":[49],"two":[51],"cases":[52],"complete.":[53],"There":[54],"was":[55,79,131],"little":[56],"toxicity":[57],"observed;":[58],"however,":[59],"antibodies":[62],"are":[63],"limited":[64],"by":[65],"their":[66,69],"immunogenicity":[67],"poor":[70],"effector":[71,128],"functions.":[72],"To":[73,125],"address":[74],"these":[75],"issues,":[76],"\"humanized\"":[77],"produced":[80],"contains":[82],"complementarity-determining":[84],"regions":[85],"from":[86,96],"mouse":[88],"remainder":[91],"molecule":[94],"derived":[95],"IgG1":[98],"kappa.":[99],"This":[100],"antibody":[101],"is":[102],"dramatically":[103],"less":[104],"immunogenic":[105],"than":[106],"murine":[108],"version,":[109],"has":[110],"improved":[111],"pharmacokinetics,":[112],"and,":[113],"contrast":[115],"to":[116,169],"parent":[118],"manifests":[120],"antibody-dependent":[121],"cellular":[122],"cytotoxicity":[123],"(ADCC).":[124],"enhance":[126],"its":[127],"function,":[129],"armed":[132],"toxins":[134],"alpha-":[136],"beta-emitting":[138],"radionuclides.":[139],"In":[140],"clinical":[142,179],"trial":[143],"90Y-anti-Tac":[145,158],"ATL":[147,167],"patients,":[148],"at":[149],"doses":[151],"used":[152],"(5,":[153],"10,":[154],"15":[156,164],"mCi":[157],"per":[159],"patient),":[160],"10":[161],"date":[170],"underwent":[171],"sustained":[172],"partial":[173],"or":[174],"complete":[175],"remission.":[176],"Thus,":[177],"application":[180],"IL-2R-directed":[182],"represents":[184],"new":[186],"perspective":[187],"for":[188,195],"prevention":[190],"allograft":[192],"rejection":[193],"treatment":[197],"graft-versus-host":[199],"disease,":[200],"select":[201],"autoimmune":[202],"disorders,":[203],"leukemia/lymphoma.":[205]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}